Pages that link to "Q34367048"
Jump to navigation
Jump to search
The following pages link to Improved Performance of Anti-miRNA Oligonucleotides Using a Novel Non-Nucleotide Modifier (Q34367048):
Displaying 50 items.
- MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics (Q26747273) (← links)
- A chemical view of oligonucleotides for exon skipping and related drug applications (Q26863684) (← links)
- Effect of Native Gastric Mucus on in vivo Hybridization Therapies Directed at Helicobacter pylori (Q27317349) (← links)
- An Interferon Regulated MicroRNA Provides Broad Cell-Intrinsic Antiviral Immunity through Multihit Host-Directed Targeting of the Sterol Pathway (Q28550521) (← links)
- miR-21/DDAH1 pathway regulates pulmonary vascular responses to hypoxia. (Q29871524) (← links)
- In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease (Q33765102) (← links)
- Arginine-rich, cell penetrating peptide-anti-microRNA complexes decrease glioblastoma migration potential (Q34032623) (← links)
- Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model (Q34117470) (← links)
- VIRmiRNA: a comprehensive resource for experimentally validated viral miRNAs and their targets (Q34446918) (← links)
- Sequence-dependent off-target inhibition of TLR7/8 sensing by synthetic microRNA inhibitors (Q35098003) (← links)
- RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration. (Q35156007) (← links)
- Towards Fluorescence In Vivo Hybridization (FIVH) Detection of H. pylori in Gastric Mucosa Using Advanced LNA Probes (Q35615550) (← links)
- Correlating In Vitro Splice Switching Activity With Systemic In Vivo Delivery Using Novel ZEN-modified Oligonucleotides. (Q35694248) (← links)
- MicroRNA as tools and therapeutics in lung cancer (Q35738706) (← links)
- MiRNA inhibition in tissue engineering and regenerative medicine (Q35799937) (← links)
- Site-specific conjugation of drug-like fragments to an antimiR scaffold as a strategy to target miRNAs inside RISC. (Q35822837) (← links)
- Evaluation of inhibition of miRNA expression induced by anti-miRNA oligonucleotides (Q36017797) (← links)
- Potential application of miRNAs as diagnostic and therapeutic tools in chronic pancreatitis (Q36057439) (← links)
- Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma (Q36232178) (← links)
- Simultaneous inhibition of multiple oncogenic miRNAs by a multi-potent microRNA sponge (Q36299692) (← links)
- Profiling olfactory stem cells from living patients identifies miRNAs relevant for autism pathophysiology (Q36443544) (← links)
- Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides (Q36532644) (← links)
- Noncoding RNAs in breast cancer (Q36935047) (← links)
- FZD6, targeted by miR-21, represses gastric cancer cell proliferation and migration via activating non-canonical wnt pathway (Q36964188) (← links)
- Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy (Q37301832) (← links)
- Sensitive and specific miRNA detection method using SplintR Ligase (Q37623750) (← links)
- New developments in the use of gene therapy to treat Duchenne muscular dystrophy (Q38168863) (← links)
- Therapeutic targeting of microRNAs: current status and future challenges (Q38228101) (← links)
- miRNAs as novel therapeutic targets and diagnostic biomarkers for Parkinson's disease: a patent evaluation of WO2014018650. (Q38259297) (← links)
- Introduction of 2,6-Diaminopurines into Serinol Nucleic Acid Improves Anti-miRNA Performance. (Q38287647) (← links)
- Non-nucleotide Modification of Anti-miRNA Oligonucleotides. (Q38289885) (← links)
- MicroRNA Therapeutics: the Next Magic Bullet? (Q38390631) (← links)
- The role of hypoxia-induced miR-210 in cancer progression (Q38391282) (← links)
- Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis? (Q38555602) (← links)
- miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart (Q38591803) (← links)
- A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease (Q38637596) (← links)
- MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment (Q38654746) (← links)
- Guidelines on Designing MicroRNA Sponges: From Construction to Stable Cell Line (Q38732127) (← links)
- SIDT2 mediates gymnosis, the uptake of naked single-stranded oligonucleotides into living cells (Q40036172) (← links)
- miR-12 and miR-124 contribute to defined early phases of long-lasting and transient memory (Q41367851) (← links)
- Control of HCV Replication With iMIRs, a Novel Anti-RNAi Agent (Q42175896) (← links)
- Enhanced antiproliferative activity of antibody-functionalized polymeric nanoparticles for targeted delivery of anti-miR-21 to HER2 positive gastric cancer (Q42366537) (← links)
- Function Control of Anti-microRNA Oligonucleotides Using Interstrand Cross-Linked Duplexes. (Q47096791) (← links)
- Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery (Q47108689) (← links)
- miRNA Targeting Drugs: The Next Blockbusters? (Q47968932) (← links)
- Functional role and therapeutic targeting of microRNAs in inflammatory bowel disease (Q49953206) (← links)
- Arsenic induces members of the mmu-miR-466-669 cluster which reduces NeuroD1 expression. (Q50091833) (← links)
- Assessing the Off-Target Effects of miRNA Inhibitors on Innate Immune Toll-Like Receptors. (Q51282064) (← links)
- Age-related changes of vitamin E: α-tocopherol levels in plasma and various tissues of mice and hepatic α-tocopherol transfer protein (Q51288724) (← links)
- Anti-miRNA oligonucleotides: A comprehensive guide for design. (Q52640764) (← links)